Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review
With the development of sequencing technology, the detection rate of non-small cell lung cancer (NSCLC) with primary epidermal growth factor receptor (EGFR) T790M mutation is increasing. However, the first-line treatment for primary EGFR T790M-mutated NSCLC still lacks standard recommendations. Here...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Chinês |
| Baskı/Yayın Bilgisi: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2023-02-01
|
| Seri Bilgileri: | Chinese Journal of Lung Cancer |
| Konular: | |
| Online Erişim: | http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.04 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|